Core Viewpoint - The control of Jiasitang (002462) is set to change hands to Tongrentang Group following a share transfer agreement, marking a significant shift in the company's ownership structure and strategic direction [2][3]. Group 1: Company Overview - Jiasitang is a leading pharmaceutical commercial enterprise in Beijing, serving over 300 secondary and tertiary hospitals with a coverage rate of 99% [3]. - The company specializes in the distribution of pharmaceuticals and medical devices, as well as healthcare products and services, aiming to become a top-tier comprehensive service provider in the domestic pharmaceutical circulation and healthcare sector [2]. - Jiasitang has faced declining profitability, with net profits decreasing from 3.54 billion yuan in 2021 to an estimated 1.61 billion yuan in 2024 [3]. Group 2: Strategic Implications of the Acquisition - The acquisition by Tongrentang Group is seen as a strategic move to enhance Jiasitang's capabilities in the pharmaceutical commercial sector, filling gaps in distribution and channel management [5]. - This transaction is expected to create a "production + commercial" closed loop, which is crucial for addressing centralized procurement and medical insurance cost control [5]. - The integration of Jiasitang under Tongrentang Group is part of a broader initiative by the Beijing State-owned Assets Supervision and Administration Commission to optimize state capital layout and strengthen the influence of state-owned capital in key public health sectors [5].

【导读】同仁堂集团有望成为嘉事堂控股股东 本次权益变动后，同仁堂集团将成为嘉事堂控股股东，北京市人民政府国有资产监督管理委员会将成为 公司实际控制人。 据同仁堂集团官网披露，同仁堂品牌始创于1669年，集团坚持以中医药为主攻方向，目前在经营格局上 形成了以制药工业为核心，以健康养生、医疗养老、商业零售、国际药业为支撑的五大板块，构建了集 种植（养殖）、制造、销售、医疗、康养、研发于一体的大健康产业链条。 目前，同仁堂集团旗下有三家上市公司，即A股的同仁堂，以及港股的同仁堂科技、同仁堂国药。 停牌前，嘉事堂股价为16.4元/股，市值为47.8亿元。 百年老店同仁堂（600085）集团有望新增一家A股上市公司。 自1月28日起停牌的嘉事堂（002462）2月3日晚公告，2月2日，公司股东中国光大医疗健康产业有限公 司（以下简称光大健康）、中国光大实业（集团）有限责任公司（以下简称光大实业）与中国北京同仁 堂（集团）有限责任公司（以下简称同仁堂集团）签署了《股份转让协议》，光大健康、光大实业拟通 过协议转让方式将其合计持有的公司股份总数的28.48%转让给同仁堂集团；转让价格为17.59元/股，转 让价款总计为14 ...

Core Viewpoint - The transaction involves the transfer of 83.06 million shares of Jiatang (嘉事堂) from China Everbright Medical Health Industry Co., Ltd. and China Everbright Industrial Group Co., Ltd. to Beijing Tongrentang Group Co., Ltd., making Tongrentang the controlling shareholder with a 28.48% stake in Jiatang [3][4][8]. Group 1: Transaction Details - The share transfer price is set at 17.59 yuan per share, totaling 1.461 billion yuan [3][4]. - After the transaction, China Everbright Medical and China Everbright Industrial will no longer hold shares in Jiatang, while Tongrentang will become the controlling shareholder [4][8]. - The transaction is subject to several conditions, including internal approvals and regulatory approvals from state asset supervision authorities [5][9]. Group 2: Company Background - Tongrentang Group is a state-owned enterprise primarily engaged in the manufacturing and sales of traditional Chinese medicine and related products [4][9]. - Tongrentang has a rich history of over 350 years and includes subsidiaries such as Tongrentang Technology and Tongrentang Guoyao, focusing on modernizing traditional medicine and expanding into global markets [4][9]. - The transferring companies, China Everbright Medical and China Everbright Industrial, are subsidiaries of China Everbright Group, with operations in health consulting, medical research, and investment management [4][9].

证券日报网讯2月3日，嘉事堂（002462）在互动平台回答投资者提问时表示，截至2026年1月30日，公 司股东共2万8千余户。 ...

Group 1 - The core point of the article is the signing of a share transfer agreement between Everbright Industrial, Everbright Health, and Tongrentang Group, resulting in a change of the controlling shareholder of the company to Tongrentang Group [1] - Everbright Industrial and Everbright Health will transfer 41.1808 million shares and 41.8764 million shares, respectively, to Tongrentang Group [1] - Following the completion of this transaction, the actual controller of the company will change to the State-owned Assets Supervision and Administration Commission of the People's Government of Beijing Municipality [1] Group 2 - The company's stock will resume trading on February 4, 2026, at the opening of the market [1]

嘉事堂（002462）即将复牌。 2月3日晚间，嘉事堂（002462）发布公告称，2月2日，公司股东光大实业、光大健康与中国北京同 仁堂（集团）有限责任公司（以下简称"同仁堂集团"）签署了《股份转让协议》，协议约定光大实 业、光大健康分别将其持有的公司约4118.08万股股份、4187.64万 股 股份转让给同仁堂集团。本次 交易完成后，公司控股股东将变更为同仁堂集团，实际控制人将变更为北京市人民政府国有资产监 督管理委员会。 公告显示，嘉事堂股票将自2026 年2 月4 日（星期三）上午开市起复牌。 责编：万健祎 校对： 许欣 版权声明 公告提示，本次协议转让尚需经主管国有资产监督管理部门批准、通过国家市场监督管理总局经营者集中 反垄断审查、通过深圳证券交易所合规性确认及向中国证券登记结算有限责任公司深圳分公司申请办理股 份转让过户登记。该事项能否最终实施完成及完成时间尚存在不确定性，请投资者注意相关风险。 综合自：公司公告 证券时报各平台所有原创内容，未经书面授权，任何单位及个人不得转载。我社保留追 究相关 行 为主体法 律责任的权利。 转载与合作可联系证券时报小助理，微信ID：SecuritiesTim ...

Buybacks and Shareholder Actions - Guizhou Moutai has repurchased a total of 416,900 shares, accounting for 0.0333% of its total share capital, with a total payment of 571 million yuan [1] - Contemporary Amperex Technology Co., Ltd. has repurchased 15,990,800 shares, representing 0.3628% of its total A-share capital, with a total transaction amount of 4.386 billion yuan [2] - SF Holding has repurchased 5,095,850 shares, which is 1.01% of its total share capital, with a total amount of approximately 2 billion yuan [10] - Wireless Media has seen its major shareholders reduce their stakes, with Wensheng Fund and its concerted parties reducing 4% of the total share capital [12] Corporate Actions and Financial Updates - Tai Ling Microelectronics announced that its second-largest shareholder, the National Integrated Circuit Industry Investment Fund, has reduced its stake from 6.95% to 5.97% by selling 2,321,300 shares [3] - Nape Mining has terminated its investment in Swiss Veritas Resources AG due to changes in delivery conditions, with no breach of contract [4] - Huangshan Tourism plans to invest approximately 530 million yuan in the construction of a hotel project, with a total building area of 79,178.15 square meters [8][9] - *ST Jinling's restructuring plan has been approved by the court, allowing the company to enter the execution phase of the plan [7] Performance and Sales - Country Garden reported a contract sales amount of approximately 2.21 billion yuan for January 2026, with a sales area of about 280,000 square meters [11] - Industrial Fulian has accumulated a total buyback fund of 247 million yuan as of January 31, 2026 [17] - Yutong Bus produced 2,167 vehicles in January 2026, a decrease of 15.35% year-on-year [17]

Group 1 - The core point of the article is that Jiatang (002462.SZ) announced a share transfer agreement with Tongrentang Group, resulting in a change of controlling shareholder and actual controller to the Beijing Municipal Government State-owned Assets Supervision and Administration Commission [1] Group 2 - The agreement involves the transfer of 41.1808 million shares and 41.8764 million shares from Guangda Industrial and Guangda Health to Tongrentang Group [1] - Following the completion of this transaction, the company's stock will resume trading on February 4, 2026 [1]

嘉事堂表示，根据《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第6号 ——停复牌》等有关规定，经公司向深交所申请，公司股票自2月4日上午开市起复牌。 北京商报讯(记者丁宁)2月3日晚间，嘉事堂（002462）发布公告称，2月2日，公司股东光大实业、光大 健康与中国北京同仁堂（600085）(集团)有限责任公司(以下简称"同仁堂集团")签署了《股份转让协 议》，协议约定光大实业、光大健康分别将其持有的公司4118.08万股股份、4187.64万股股份转让给同 仁堂集团。本次交易完成后，公司控股股东将变更为同仁堂集团，实际控制人将变更为北京市人民政府 国有资产监督管理委员会。 ...

本次权益变动后，同仁堂集团将成为公司控股股东，北京市人民政府国有资产监督管理委员会（以下简 称"北京市国资委"）将成为公司实际控制人。公司股票（证券简称：嘉事堂，证券代码：002462）自 2026年2月4日（星期三）上午开市起复牌。 格隆汇2月3日丨嘉事堂(002462.SZ)公布，公司股东光大健康、光大实业与同仁堂集团签署了《股份转 让协议》，光大健康、光大实业将合计持有的公司83,057,236股股份（占公司股份总数的28.48%）转让 给同仁堂集团，转让价格为人民币17.59元/股，转让价款总计为人民币1,460,976,781.24元。其中光大健 康将其持有的公司41,876,431股股份（占公司总股本的14.36%）转让给同仁堂集团，转让价款为人民币 736,606,421.29元；光大实业将其持有的公司41,180,805股股份（占公司总股本的14.12%）转让给同仁堂 集团，转让价款为人民币724,370,359.95元。 ...